Revagenix Doses First Patient in Phase 1 Rev-56 Trial
SAN FRANCISCO, Calif., July 27, 2026 Revagenix, Inc. announced that the first participant has been dosed in the Phase...
inhaled therapy
Advertisement
Kinaset Doses First Patient in Phase 2b Frevecitinib Trial
BOSTON, MA, July 20, 2026 Kinaset Therapeutics announced that the first patient has been dosed in the Phase 2b...
Sino Biopharm Secures $2.1B TQC3721 AstraZeneca Agreement
HONG KONG, July 8, 2026 Sino Biopharmaceutical Limited has announced that its subsidiary, Chia Tai Tianqing Pharmaceutical Group Co.,...
Kither Biotech Completes Phase 1 Trial of KIT2014
TURIN, Italy | June 19, 2026 Kither Biotech has announced the successful completion of its first-in-human Phase 1 clinical...
Advertisement
